Syngene International

Within pharma, the CDMO segment is touted as the fastest-growing. Here are some undervalued companies in this space to track.

Buy or sell stocks for 16 March: Vaishali Parekh recommends two intraday stocks to buy today — Syngene International, Tata Consumer Products

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Syngene International, Muthoot Finance, and Tata Consumer Products

Buy or sell: Vaishali Parekh recommends three intraday stocks to buy today — Syngene International, Carborundum Universal, and Hyundai Motor India

Here are a list of 5 CDMO stocks that you can add to your watchlist as the industry continues to see good growth.

Continued inventory correction for Syngene’s largest commercial biologics product drags earnings for a second straight quarter.

India's CRDMO sector is set for growth in the next 3-5 years, with Jefferies highlighting four stocks including Divi's Labs, Sai Life are expected to gain 17-30%. Concerns persist regarding high valuations and earnings volatility for Laurus Labs, which received an 'Underperform' rating.

Mirae Asset Mutual Fund has slightly decreased its stake in Syngene International to 2.95% by selling 667,386 shares. Syngene, which reported a 59% rise in Q1 FY26 profit, remains under stock pressure despite a significant long-term gain since March 2020.